XOMA Royalty Corp
XOMA26.740USD
-0.750-2.73%
Close 05/14, 16:00（ET）Quotes delayed by 15 min
319.61MMarket Cap
LossP/E TTM
More Details of XOMA Royalty Corp Company
XOMA Royalty Corporation is a biotechnology royalty aggregator. The Company’s royalty aggregator business is primarily focused on early to mid-stage clinical assets, primarily in Phase I and II, with significant commercial sales potential that are licensed to funded partners. The Company has a portfolio of economic rights and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The Company's royalty portfolio includes OJEMDA (tovorafenib), Cetrelimab (JNJ-63723283), Ersodetug (RZ358), MIPLYFFATM (arimoclomol), Acimtamig (AFM13), Ficlatuzumab (AV-299), COM902, Vosaroxin, Aldoxorubicin, MNPR-101, PBF-680, PBF-677, PBF-999, PBF-1129, PBF-1650, DSUVIA (sufentanil sublingual tablet), IXINITY, Vidutolimod (CMP-001), MT-0169, RZ-402, G03-52-0, AFM24, Mezagitamab (TAK-079), among others.
Company Info
Company codeXOMA
Company nameXOMA Royalty Corp
IPO dateJun 06, 1986
Founded at2011
CEOMr. Owen P. Hughes, Jr.
Number of employees13
Security typeOrdinary Share
Fiscal year-endJun 06
Address2200 Powell Street
CityEMERYVILLE
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code94608
Phone15102047239
Websitehttps://www.xoma.com/
Company codeXOMA
IPO dateJun 06, 1986
Founded at2011
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
6.46K
-48.42%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
--
-100.00%
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Mr. Owen P. Hughes, Jr.
Mr. Owen P. Hughes, Jr.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Bradley J. (Brad) Sitko
Mr. Bradley J. (Brad) Sitko
Chief Investment Officer
Chief Investment Officer
--
--
Ms. Heather L. Franklin
Ms. Heather L. Franklin
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Jack L. Wyszomierski
Mr. Jack L. Wyszomierski
Independent Chairman of the Board
Independent Chairman of the Board
6.46K
-48.42%
Mr. Joseph M. (Joe) Limber
Mr. Joseph M. (Joe) Limber
Independent Director
Independent Director
6.21K
-0.03%
Mr. Thomas (Tom) Burns
Mr. Thomas (Tom) Burns
Chief Financial Officer, Senior Vice President - Finance
Chief Financial Officer, Senior Vice President - Finance
--
--
Ms. Natasha A. Hernday
Ms. Natasha A. Hernday
Independent Director
Independent Director
--
-100.00%
Ms. Barbara A. Kosacz, J.D.
Ms. Barbara A. Kosacz, J.D.
Independent Director
Independent Director
--
--
Mr. Matthew D. Perry
Mr. Matthew D. Perry
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdate time: Sun, Apr 6
Currency: USDUpdate time: Sun, Apr 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
No Data
By RegionUSD
Name
Revenue
Proportion
Switzerland
14.80M
51.95%
United States
12.06M
42.34%
Asia Pacific
1.13M
3.95%
Europe
500.00K
1.76%
By Business
By Region
No Data
Shareholder
Update time: Mon, May 5
Update time: Mon, May 5
Shareholder Statistics
Type
Shareholder Statistics
Shareholder
Proportion
BVF Partners L.P.
24.96%
Fidelity Management & Research Company LLC
8.69%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Morgan Stanley Investment Management Inc. (US)
2.45%
Other
55.96%
Shareholder Statistics
Shareholder
Proportion
BVF Partners L.P.
24.96%
Fidelity Management & Research Company LLC
8.69%
BlackRock Institutional Trust Company, N.A.
4.10%
The Vanguard Group, Inc.
3.84%
Morgan Stanley Investment Management Inc. (US)
2.45%
Other
55.96%
Type
Shareholder
Proportion
Hedge Fund
29.64%
Investment Advisor
17.31%
Investment Advisor/Hedge Fund
11.96%
Individual Investor
0.80%
Research Firm
0.42%
Bank and Trust
0.07%
Pension Fund
0.03%
Insurance Company
0.02%
Other
39.75%
Institutional Shareholding
Update time: Wed, Mar 5
Update time: Wed, Mar 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q1
148
7.24M
60.53%
-991.01K
2024Q4
151
7.96M
67.53%
-445.61K
2024Q3
149
7.79M
66.29%
-572.80K
2024Q2
143
7.78M
66.74%
-664.29K
2024Q1
144
7.71M
66.30%
-615.38K
2023Q4
149
7.62M
66.29%
-820.22K
2023Q3
146
7.80M
68.02%
-670.64K
2023Q2
148
7.93M
69.11%
+32.68K
2023Q1
155
7.51M
65.57%
+97.45K
2022Q4
157
7.16M
62.50%
-122.23K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
BVF Partners L.P.
2.98M
24.9%
-650.72K
-17.91%
Jan 24, 2025
Fidelity Management & Research Company LLC
1.04M
8.69%
-4.36K
-0.42%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
498.79K
4.16%
+6.57K
+1.33%
Dec 31, 2024
The Vanguard Group, Inc.
463.84K
3.87%
+41.45K
+9.81%
Dec 31, 2024
Morgan Stanley Investment Management Inc. (US)
292.74K
2.44%
+140.95K
+92.86%
Dec 31, 2024
Opaleye Management Inc.
250.00K
2.09%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
182.19K
1.52%
-551.00
-0.30%
Dec 31, 2024
Woodline Partners LP
156.27K
1.3%
+60.93K
+63.91%
Dec 31, 2024
State Street Global Advisors (US)
144.53K
1.21%
+1.67K
+1.17%
Dec 31, 2024
Stonepine Capital Management, LLC
125.70K
1.05%
-69.40K
-35.57%
Dec 31, 2024
View more
Related ETFs
Update time: Tue, May 6
Update time: Tue, May 6
Name
Proportion
iShares Micro-Cap ETF
0.03%
ProShares Hedge Replication ETF
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Global X Russell 2000 ETF
0.01%
Proshares Ultra Russell 2000
0.01%
Avantis US Equity ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Russell 2000 Value ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.03%
ProShares Hedge Replication ETF
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 2000 Growth ETF
Proportion0.01%
ProShares UltraPro Russell2000
Proportion0.01%
Global X Russell 2000 ETF
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
Avantis US Equity ETF
Proportion0%
Avantis US Small Cap Equity ETF
Proportion0%
iShares Russell 2000 Value ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data